As AI tools introduce unilateral decision-making in the construction industry, the standards for adoption increase.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The Trump administration is planning to use artificial ...

We frequently question whether we are alone in the universe. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Breaking space news, the latest ...

Scarlett Howard currently has funding from the Australian Research Council and the Hermon Slade Foundation. Adrian Dyer receives funding from the Australian Research Council, the Alexander von ...

Billions of dollars are flowing into humanoid robot startups, as investors bet that the industry will soon put humanlike machines in warehouses, factories and our living rooms. Many leaders of those ...

Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block perfectly with vaccines alone. To solve this problem, KAIST's research team has ...

Nvidia rebutted a report that the Chinese AI startup DeepSeek has been using smuggled Blackwell chips to develop its upcoming model. "We haven't seen any substantiation," an Nvidia spokesperson said ...

Nov 18 (Reuters) - Switzerland's Barry Callebaut (BARN.S), opens new tab said on Tuesday it would partner with Chilean start-up NotCo AI to utilise artificial intelligence in recipe development, as it ...

Passive radar and radio frequency solutions company Hidden Level has introduced DroneOps, “a spatial computing app for Apple Vision Pro that transforms live airspace data into an intuitive, immersive ...

Students at California State University, Northridge are working to develop robotic prosthetics using artificial intelligence. NBC News' Gadi Schwartz visits the school to talk to the students and test ...

WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs for immunological, inflammatory, and ...